(Q37038650)

17 August 2017

Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer (English)

1 reference

17 August 2017

1 reference

6

Karin Jirström

1 reference

17 August 2017

Annika Jögi

2

0 references

Signe Borgquist

object named as

Signe Borgquist

series ordinal

1

0 references

Fredrik Pontén

series ordinal

3

object named as

Fredrik Pontén

1 reference

17 August 2017

Lisa Rydén

4

1 reference

PMCID

2614512

17 August 2017

Donal J Brennan

series ordinal

5

1 reference

17 August 2017

22 September 2008

1 reference

17 August 2017

Breast Cancer Research

1 reference

17 August 2017

10

1 reference

17 August 2017

5

1 reference

17 August 2017

R79

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2146

17 August 2017

0 references

cites work

Statins and cancer: A systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Do the cholesterol-lowering properties of statins affect cancer risk?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Statin use and breast cancer risk in a large population-based setting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Breast cancer growth prevention by statins

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Statins and the risk of colorectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Isoprenoids as mediators of the biological effects of statins

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Tissue microarrays for high-throughput molecular profiling of tumor specimens

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

Requirement for mevalonate in the control of proliferation of human breast cancer cells

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614512

The Malmo Diet and Cancer Study. Design and feasibility

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18808688

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Risk of Cancer in Users of Statins

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18808688

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/BCR2146

1 reference

PMCID

2614512

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

1 reference

PMCID

2614512